한국어
English
日本語
中文(简体)EGF Topical Solution 0.005% (Recombinant Human Epidermal Growth Factor)
0.5mg
Solution · Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Recombinant human epidermal growth factor is a growth factor that helps in skin wound healing and regeneration.
MFDS ingredient code M247622
Recombinant human epidermal growth factor is a protein growth factor that promotes the growth and regeneration of human skin cells. It is produced using genetic engineering with Escherichia coli and is used in pharmaceuticals for wound treatment and skin regeneration.
This ingredient promotes the proliferation and differentiation of skin cells, helping damaged skin tissue recover rapidly. It activates cell regeneration to accelerate the healing process in wound areas.
Approved uses differ by product. Check each product's information for its actual use.
Recombinant human epidermal growth factor has the same structure as naturally occurring growth factors but is mass-produced in Escherichia coli, ensuring high safety and efficacy. Unlike other growth factors, it is specialized for skin regeneration and is primarily used for wound treatment.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.